We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Landmark Patents Issued for MRI-Guided Radiation Therapy

By MedImaging International staff writers
Posted on 06 Jun 2011
Print article
US and European patents have been issued for innovative magnetic resonance imaging (MRI)-guided radiation therapy technology.

The core technology of ViewRay, Inc. (Cleveland, OH, USA), a unique combination of MRI and radiotherapy technologies, has been issued landmark patents in the United States and Europe. ViewRay, a privately held medical device company, holds the exclusive worldwide license for the technology from the University of Florida (UF; Gainesville, USA). The cancer treatment technology was invented by company founder James F. Dempsey, PhD, while he was a member of the radiation oncology faculty at the University of Florida.

The patented technology is key to ViewRay's new radiation therapy system, which is being designed to capture soft-tissue images continuously during treatment. "The technology is intended to enable clinicians to see precisely where the radiation is being delivered, as it's being delivered," said Dempsey, now ViewRay's chief scientific officer. "Our goal is to allow clinicians to know, to control, and to optimize the dose to the patient." Broadly covering both the medical device and the method of implementation, the patents acknowledge the unique combination of simultaneous MRI and radioisotope irradiation.

The University of Florida encouraged Dr. Dempsey to bring his invention to the marketplace, where it could begin to benefit cancer patients, and ViewRay was formed. The ViewRay system, now in the late stages of development, is currently available only as a not-for-human use research system. The company is working to secure FDA clearance for commercial distribution of the system for clinical use. "These are landmark patents," said David L. Day, director of the University of Florida Office of Technology Licensing. "We believe they are important pieces of intellectual property that can provide significant competitive advantages in the radiation therapy industry."

ViewRay is a medical device company developing advanced radiation therapy technology for the treatment of cancer. Using MRI-guided radiotherapy, the ViewRay system is being designed to provide continuous soft-tissue imaging during treatment.

Related Links:

View Ray
University of Florida


New
Gold Member
X-Ray QA Meter
T3 AD Pro
Wall Fixtures
MRI SERIES
LED-Based X-Ray Viewer
Dixion X-View
New
Portable Color Doppler Ultrasound System
S5000

Print article
Radcal

Channels

Radiography

view channel
Image: The new X-ray detector produces a high-quality radiograph (Photo courtesy of ACS Central Science 2024, DOI: https://doi.org/10.1021/acscentsci.4c01296)

Highly Sensitive, Foldable Detector to Make X-Rays Safer

X-rays are widely used in diagnostic testing and industrial monitoring, from dental checkups to airport luggage scans. However, these high-energy rays emit ionizing radiation, which can pose risks after... Read more

MRI

view channel
Image: The scans revealed a new dimension of brain network organization in humans (Photo courtesy of Georgia State University/TReNDS Center Research)

New Approach Identifies Signatures of Chronic Brain Disorders Using fMRI Scans

Traditional studies of brain function, often using fMRI scans to detect brain activity patterns, have shown promise in identifying changes in individuals with chronic brain disorders like schizophrenia.... Read more

Nuclear Medicine

view channel
Image: Example of AI analysis of PET/CT images (Photo courtesy of Academic Radiology; DOI: 10.1016/j.acra.2024.08.043)

AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer

Immunotherapy has significantly advanced the treatment of primary lung cancer, but it can sometimes lead to a severe side effect known as interstitial lung disease. This condition is characterized by lung... Read more

General/Advanced Imaging

view channel
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.